A deproteinised calf blood preparation for use in prevention or treatment of post-stroke cognitive impairment
EP2356984A1
Improved distigmine bromide formulation
AT502891A1
Method for manufacturing material for sealing and healing wounds, involves filling suspension into container, which forms base frame and base of container having upper and lower perforated plate
EP1282406A1
Pharmaceutical kit comprising midodrine as an active drug substance
US7070803B2
Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
US6761904B2
Pharmaceutical kit comprising midodrine as active drug substance
WO9832738A1
New compounds with hemoregulating effect
ATA16597A
New substituted p-sulfonylaminobenzol sulfonic acid
ATA156496A
Pharmaceutical composition
CA2230036A1
Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
ATA93296A
Use of a human cell line for identifying and determining substances for inhibiting the induction of the expression of the cyclooxygenase-2 gene
ATA27696A
Use of the human megakaryocytic cell line dami for identifying and determining substances for inhibiting the enzymatic activity of the enzyme cyclooxygenase-1
ATA168395A
New morphine-6-glucuronide crystal shape
ATA89695A
Antibodies for detecting and for distinguishing truncated and non-truncated forms of chemokines
ATA64793A
Device for evenly applying a suspension to a collage carrier
